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Decreased cerebral blood ﬂow in the limbic and
prefrontal cortex using SPECT imaging in a
cohort of completed suicides
K Willeumier, DV Taylor and DG Amen
Suicide has a high comorbidity with impulsivity and depression, and ﬁnding imaging biomarkers indicative of patients at high
risk for suicidal behavior is invaluable to the clinician. Using single-photon emission computed tomography (SPECT) imaging,
wehavepreviouslyreportedregionalcerebralbloodﬂow(rCBF)decreasesinthemedialprefrontalcortex,ventraltegmentalarea
and subgenual cingulate cortex (Brodmann area 25 (BA 25)), a region found to be hypoperfused with treatment-resistant
depression. From 2007 to 2010, we have extended our analysis to include nine additional completed suicides. In all, 27 healthy,
age- and gender-matched subjects from a previously acquired healthy brain study served as controls to our 21 completed
suicides. All 21 suicides had been previously diagnosed with depression according to Diagnostic and Statistical Manual of
Mental Disorder-IV criterion. Voxel-by-voxel analyses were performed using statistical parametric mapping to compare
the differences in technetium-99m hexamethylpropylene amine oxime brain uptake between the groups. Factor analysis of the
data identiﬁed the top 10 regions of hypoperfusion in the suicidal group, including the bilateral superior frontal lobes, the right
precuneus, the rolandic operculum, postcentral gyrus, left caudate and insular cortex. We also demonstrate more focal
decreases in rCBF in the subgenual cingulate cortex (BA 25) in 18 subjects, supporting our previous hypothesis that
hypoperfusion of BA 25may be a risk factor for suicide indepressedpatients. This work suggests that SPECT might be useful in
predictingriskforsuicidecompletioninsubjectswithdepressionortreatment-resistantdepression.Furtherinvestigationofthis
work is necessary to better understand the predictive value of this ﬁnding.
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Introduction
The World Health Organization estimates that 1000000
people die yearly from suicide.
1 Although suicide is growing
at an alarming rate, it is a poorly understood psychiatric
disorder and is currently ranked among the top 10 leading
causes of death in the United States,
2 with 16 suicides
committed per every 100000 individuals worldwide.
1 Analysis
of data from the US National Comorbidity Survey-Replication,
the ﬁrst nationally representative mental health survey
in the United States, revealed that 80% of suicide attempts
were due to mental disorders, primarily related to anxiety,
mood, impulse control and substance abuse.
3 Of the mental
disorders, major depressive disorder is considered one
of the top four psychiatric risk factors associated with
an increased predisposition towards suicidal ideation and
attempted suicide.
4 The use of anatomical and functional
imaging studies to expand our understanding of the neuro-
biology underlying suicide is clearly needed.
The etiology of suicide is complex, and most likely it is the
subtle neuroanatomic changes that result in the social and
emotionalproblemsobservedinthesepatients.Assuicidehas
many comorbid risk factors, determining causality requires
understanding the extent to which comorbidity effects brain
structure and function. Bipolar disease is one such comorbid-
ity, and several neuroanatomic imaging studies suggest
that this is a disorder that results in decreased gray matter
volume in the subgenual prefrontal cortex (Brodmann area
25 (BA 25)).
5–7 The subgenual prefrontal cortex is impor-
tant in the regulation of mood and emotions, and bilateral
decreases in brain volume have been observed in individuals
with major depressive disorder.
8 We have previously reported
a decrease in rCBF in the subgenual prefrontal cortex
in a small cohort of completed suicides.
9 Interestingly, in
patients with treatment-resistant depression, single-photon
emission computed tomography (SPECT) imaging has been
usedtoshowincreasedrCBFinthesubgenualcingulategyrus
in patients who were positive responders to citalopram.
10
Taken together, these results suggest that decreased activity
of the subgenual cingulate gyrus in those with depression or
mood disorder may be predisposed to suicidal tendencies.
The aim of this study was to retrospectively analyze a
cohortofpsychiatricpatientswhohavecommittedsuicideand
compare the changes in rCBF to that of a previously acquired
healthy brain cohort. Our prior data on 12 completed suicides
revealed a unique ﬁnding of hypoperfusion in the subgenual
cingulate cortex (BA 25). Furthermore,we analyzed this cohort
against a group of depressed, non-suicidal subjects with similar
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www.nature.com/tpclinical proﬁles. Overall, we aim to further characterize the
underlying rCBF deﬁcits in this cohort of completed suicides
who exhibit depression as a comorbid factor.
Methods
Using a previously acquired database of over 64000 SPECT
scans from patients seen across four clinics in the United
States, we retrospectively pulled the data of 21 completed
suicides, which occurred from 1992 to 2010. Within this time
frame, 38000 patients had been evaluated at one of the
clinics, of which 74% were diagnosed as having a mood
disorder or depression. All patients in the suicide group had
been previously evaluated by a board-eligible or -certiﬁed
psychiatrist for depression. They each underwent a detailed
clinical history, mental status examination and Beck Depres-
sion Inventory (BDI). Table 1 outlines the patient demo-
graphics and psychiatric history and Table 2 gives a proﬁle of
the medication history for each patient at the time of the visit.
All of the subjects ﬁt the clinical criteria for depression based
on the BDI, Diagnostic and Statistical Manual of Mental
Disorder-IV (DSM-IV) or had been given a diagnosis of mood
Table 1 Suicide cohort demographics and psychiatric diagnoses
Age
(years)
Gender BDI Depre-
ssed
Mood
disorder
Bipolar Suicidal
ideations
Suicide
attempt
ADHD PTSD Anxiety Drug
use
Head
trauma
Sexual
abuse
Months
to death
41 M NA x x 14
51 M 19 x x 3
41 F 36 x x x 89
26 M 5 x x x x 1
64 M 27 x
42 F 40 x x x x 12
50 M NA x x x 9
21 M 19 x x x x x
21 M 34 x x x x x x 14
36 F NA x x x x x 6
15 M 99 x x x x x x
39 M 46 x x x x x x x x
63 M 38 x x x x x x 37
43 M 24 x x x x x x x x 15
33 M 31 x x x x x x 2
20 M 11 x x x 9
45 F 32 x x x x 7
19 M 16 x x x x x
34 M NA x x x x x x x 45
28 F 34 x x x x 20
23 M NA x x x x x x x 7
Abbreviations: ADHD, attention deﬁcit hyperactivity disorder; BDI, Beck Depression Inventory; DSM-IV, Diagnostic and Statistical Manual of Mental Disorder-IV;
NA, not applicable; PTSD, post-traumatic stress disorder; SPECT, single-photon emission computed tomography.
In all, 21 subjects ranging in age from 15 to 64 years previously underwent a psychiatric evaluation and brain SPECT imaging. A BDI score of 25 or greater results in
the diagnosis of depression as deﬁned by the DSM-IV criterion. An ‘x’ in the category of depression, mood disorder or bipolar was given based on a diagnostic
evaluation from a treating psychiatrist. The mean time from clinic visit to suicide was 18±22 months. The exact time of death data was unavailable for ﬁve of the
subjects listed.
Table 2 Suicide cohort medication history
Patient Antidepressants Antianxiety
medications
Mood
stabilizers
ADHD
medications
Antipsychotic Sleep aid
1 x
2x x
3
a
4
a
5x x x
6x x
7x x x x
8x x x x
9x x x
10 x x
11 x x x
12 x x x x
13 x x
14 x x x x
15 x x x x
16 x xx
17 x
18
a
19 x x x x
20 x
21 x
Abbreviation: ADHD, attention deﬁcit hyperactivity disorder.
All 21 subjects were off medications for the appropriate washout period before being scanned. The medication history of each patient listed is at the time of visit.
aMedication history was not available.
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Translational Psychiatrydisorder. Within this group, 16 patients had at least one prior
suicide attempt, and nine had expressed suicidal ideations. In
addition, 13 patients had been diagnosed with attention deﬁcit
hyperactivity disorder (ADHD) as measured by DSM-IV
criteria. A total of 12 patients had experienced prior head
trauma and 11 had problems with substance abuse. In all, 27
subjects previously acquired under an institutional review
board-approved healthy brain study were selected who were
within 5 years of age and the same gender as at least one
member of the suicide cohort. Two participants in our suicide
group were not age matched within 5 years as we did not
have elderly males aged 63 and 64 years in our healthy brain
subjects (HBSs). The mean age of the suicide cohort was
36±14.0 years (15–64 years), whereas the mean age of the
healthy brain cohort was 35±9.6 years (20–52 years).
We next compared our group of 21 completed suicides
to a control group of 36 non-suicidal depressed patients.
Depressedcontrolswereselectedbyusingasearchalgorithm
that matched each subject with someone of the same gender
who was within 10 years of age, without suicide ideation or
history of suicide attempt and whose diagnostic proﬁle
matched the criteria of having depression, anxiety disorder,
bipolar disorder and head trauma. Two passes of the search
algorithm were run to arbitrarily select two matches for each
suicidesubject.Onlyonematchwasfoundforeachsubjecton
the ﬁrst pass and on the second pass matches were found for
15 subjects giving a set of 36 non-suicidal depressed controls
with an average age of 36±15 years (15–66 years).
SPECT scans. Each subject underwent high-resolution
brain SPECT imaging to measure regional cerebral blood
ﬂow (rCBF) as part of their evaluation. Each subject received
an age/weight-appropriate dose of technetium-99m
hexamethylpropylene amine oxime intravenously. Subjects
were injected in normal lighting while they performed the
Conner’s Continuous Performance Test II. The radiopharma-
ceutical was injected 3min after starting the 15-min test. All
subjects completed the task. Subjects were then scanned
30min later using a high-resolution Picker Prism 3000 triple-
headed gamma camera with fan beam collimators, acquiring
data in 128 128 matrices, yielding 120 images per scan,
with each image separated by 31 spanning 3601.
SPECT data were processed and attenuation correction
performed using general linear (Chang) methods. All images
werereconstructed andreslicedusinganobliquereformatting
program, according to anterior–posterior commissure line, so
that the ﬁnal images were similarly aligned for analysis.
Image analysis. Differences in hexamethylpropylene amine
oxime uptake were analyzed using the SPM8 software
(Wellcome Department of Cognitive Neurology, London, UK)
implemented on the Matlab platform (MathWorks Inc.,
Sherborn, MA, USA). Statistical parametric maps (SPMs)
are spatially extended statistical processes that are
constructed to test hypotheses about regionally speciﬁc
effects in neuroimaging data. SPM combines the general
linear model and the theory of Gaussian random ﬁelds to
make statistical inferences about regional effects.
11 The
images were spatially normalized using a 12-parameter
afﬁne transformation, followed by nonlinear deformations
12
to minimize the residual sum of squares between each scan
and a reference or template image conforming to the
standard space deﬁned by the Montreal Neurological
Institute template. The original image matrix obtained at
128 128 29 with voxel sizes of 2.16 2.16 6.48mm
3
was transformed and resliced to a 79 95 68 matrix
with voxel sizes of 2 2 2mm
3 consistent with the
Montreal Neurological Institute template. Images were
smoothed using an 8mm full-width at half-maximum
isotropic Gaussian kernel.
Data analysis. We compared the SPECT scans from the
suicide cohort versus the healthy brain cohort using SPM
with a two-sample t-test using covariance to control for the
effects of age and gender. Factorial modeling in SPM was
used for regression of the binary variable having completed
suicide against rCBF while using covariance to control for the
effects of age and gender.
Results
We age and gender matched our suicide cohort of 21 subjects
with27HBSs.Withinthesuicidecohort,allhadmettheclinical
criteria of having depression as measured by the BDI and
DSM-IV. Additional comorbidities within this group include
attention deﬁcit hyperactivity disorder, post-traumatic
stress disorder, anxiety, substance abuse and head trauma
(see Table 1). Over half of the subjects had dual diagnoses of
depression with ADHD, substance abuse or head trauma. In
total, 16 subjects report one prior suicide attempt, with nine
having experienced incidence of suicidal ideations. Issues
with post-traumatic stress disorder, physical violence and
sexual abuse were also reported within this cohort, but the
incidence was low. Within the HBS group, each had met
the clinical criteria for a healthy brain subject, which included
the absence of current medical illnesses, past brain trauma,
family history of psychiatric illness, current or past drug or
alcoholabuseandnocurrentorpastevidenceofneurological,
behavioral or psychiatric issues as measured by a detailed
clinical history, Minnesota Multiphasic Personality Inventory
and Structured Clinical Interview for Diagnosis for DSM-IV.
The mean age for the suicide cohort was 36±14.0 years
(16 men, 5 women), whereas for the HBS cohort, it was
35±9.6 years (17 men, 11 women). SPM analysis on the
concentration brain SPECT imaging scans of the suicide
group revealed diffuse regions of hypoperfusion across the
brain at Po1 10
 10 family-wise error (FWE) corrected as
compared to the HBS group. Figure 1 depicts the three-
dimensional (3D) cortical surface views showing global brain
SPECT decreases in rCBF in the suicide subjects.
To determine which deﬁcits in rCBF were most predictive of
being in the suicide group, we used multiple regression
analysis within SPM and controlled for age and gender.
The 10 most signiﬁcant regions of decreased rCBF in terms of
cluster size that were found to be most predictive of the
suicide cohort are listed in Table 3. Factor analysis revealed
the ﬁve most predictive areas of reduced blood ﬂow in suicide
patients include the bilateral superior frontal lobes, right
precuneus, rolandic operculum, postcentral gyrus and left
caudate–thalamus. The regional areas as identiﬁed through
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Translational PsychiatrySPM analysis are as follows: Region 1 shows the most
signiﬁcant decrease in rCBF with an overall cluster size of 520
voxels and is located in the right precuneus (coordinates 18,
 48, 16; t¼4.84). Region 2 encompasses the frontal
lobes with a cluster size of 505 voxels in the right frontal
superior medial cortex (coordinates 14, 46, 46; t¼4.53) and
373 voxels in the left frontal superior cortex (coordinates  16,
48, 42; t¼4.35). Regions 3–5 include the rolandic operculum
(coordinates 42,  12, 22; t¼4.17), left postcentral gyrus
(coordinates  48,  12, 58; t¼4.12) and left caudate
(coordinates  12,  16, 22; t¼4.11). Figure 2 shows the 3D
cortical representation of these brain regions and Figure 3
illustrates these areas through transverse, coronal and
sagittal slices (Po0.05, FWE).
A region-of-interest analysis was applied to BA 25.
Individual analysis revealed that 18 subjects had decreased
rCBF in BA 25 as compared with HBSs. Of these subjects, 13
were 1s.d. below the mean from the HBS. Group analysis
showed that the suicide cohort had a lower overall average
rCBF in BA 25 as compared with our healthy brain cohort at
P¼0.001 and t¼3.45 (suicide cohort: 509±200; HBS:
668±115). No signiﬁcant increases were observed.
To further differentiate the changes in rCBF in our suicide
cohort from a group of depressed patients with a similar
clinical proﬁle who are non-suicidal, we performed an SPM
analysis on concentration SPECT scans and found diffuse
regions of hypoperfusion in rCBF throughout the brain of the
suicide group at Po1 10
 5 FWE. Figure 4 depicts the
3D cortical surface views showing global brain SPECT
decreases.WhencomparingavailableBDIscores,thesuicide
cohort (n¼15) scored higher (27.5±11.5) than the non-
suicidal cohort (n¼27) (15.0±7.0) (t(40,2)¼ 4.36, Po0.01).
Figure 1 Three-dimensional (3D) surface images showing global brain single-
photon emission computed tomography (SPECT) decreases in suicide subjects
versus healthy brain subjects. Cortical surface views show decreased regional
cerebral blood ﬂow in suicide subjects at Po1 10
 10, family-wise error (FWE ).
Signiﬁcant decreases are in blue. No increases were observed.
Table 3 Top 10 regions of decreased rCBF predictive of suicide relative to a
healthy brain cohort at Po0.05 FWE
Brain area Cluster size t x y z
Precuneus 520 4.84 18  48 16
Right frontal lobe 505 4.53 14 46 46
Left frontal lobe 373 4.35  16 48 42
Rolandic operculum 345 4.17 42  12 22
Postcentral left 262 4.12  48  12 58
Caudate–thalamus 317 4.11  12  16 22
Insula 260 4.1 32 18 12
Caudate–putamen—R 427 3.99 10 12 12
Frontal inferior orbital 90 3.96 28 36  4
Insula–putamen 64 3.91  26 20 12
Abbreviation: rCBF, regional cerebral blood ﬂow.
Figure 2 Three-dimensional (3D) surface images showing regional cerebral
blood ﬂow (rCBF) deﬁcits predictive of suicide. Cortical surface views show areas of
decreased rCBF, which predict suicide at Po0.05, family-wise error (FWE).
Signiﬁcant decreases are in blue.
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depressed non-suicidal cohort and suicide cohort showed
that rCBF throughout the brain continued to decrease with
severity of illness (Po1 10
 10).
A regression model demonstrating decreases in rCBF
predictive of suicide using the two clinical populations
revealed large, diffuse clusters throughout the brain, but at a
low level of signiﬁcance (Po0.01 without FWE). Figure 5
shows the 3D cortical representation of these brain regions.
The results did not survive higher signiﬁcance criteria; hence,
these large clusters could not be reduced. However, we
observed a trend of decreases in the frontal, temporal
and parietal areas associated with suicide completion. The
10 most signiﬁcant regions of decreased rCBF in terms of
cluster size found to be most predictive of the suicide between
these clinical proﬁles are listed in Table 4.
Discussion
The use of neuroimaging tools can be valuable in elucidating
the neurobiological correlates underlying suicidal behavior.
Here, we report the results of 21 completed suicides along
with their comorbidities in an effort to better understand the
alterations in metabolism and activity patterns that underlie
this growing epidemic. We compared these subjects to a
previously acquired database of SPECT scans from healthy
patients, who have no prior psychiatric history and no family
history of psychiatric behavior. This database allowed us to
age and gender match this group to our suicide cohort.
We also had extensive psychiatric proﬁles on each patient,
allowing for deeper examination into the relationship between
the SPECT ﬁndings and their clinical correlates.
Our primary ﬁnding demonstrates global decreases in
blood ﬂow and activity patterns in the suicide group versus a
healthy comparison group. This ﬁnding was robust, even at
Po1 10
 10, and given the comorbidity of depression,
ADHD, head trauma and bipolar diagnosis in our suicide
cohort may indicate compromise among numerous neuronal
pathways. However, although such comorbidity is often
observable in clinical populations, not all of these cases end
Figure 3 Image sections showing regional cerebral blood ﬂow (rCBF) decreases predictive of completing suicide. Transverse, coronal and sagittal sections showing
predictiveareasofsuicide:Transverse49—postcentralleft;69—rightandleftfrontalareas;88—frontalinferiorright,postcentralright,caudateright,thalamusright,precuneus
right; 94—frontal inferior right, postcentral right, caudate right, thalamus right, precuneus right; 97—insular cortex right, caudate right, insular cortex left, precuneus right;
113—insular cortex right, frontal inferior orbital left (Brodmann area (BA) 25). Coronal 36—left and right frontal lobes; 49—frontal superior right, frontal superior left, insular
cortex; 56 frontal superior right, frontal superior left, inferior frontal right, frontal inferior orbital left (BA25); 74—insular cortex right, caudate right, insular cortex left;
104—rolandicoperculumright,thalamusright,postcentralleft,144—precuneusright.Sagittal45—rolandicoperculumright;60—frontalcortexright,insularcortexright,frontal
inferior cortex right (BA 25); 76—frontal cortex, caudate right, precuneus; 80—frontal cortex, caudate, thalamus right, precuneus; 97—frontal inferior orbital left (BA 25),
thalamus; 138—postcentral left.
Figure 4 Three-dimensional (3D) surface images showing global brain single-
photon emission computed tomography (SPECT) decreases in suicide cohort
versus depressed non-suicidal cohort. Cortical surface views show diffuse regions
of decreased regional cerebral blood ﬂow in suicide subjects at Po1 10
 5,
family-wise error (FWE) in comparison to non-suicidal subjects with matched
diagnostic proﬁles. Signiﬁcant decreases are in blue. No increases were observed.
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of factorial modeling allowed us to differentiate distinct areas
of neuronal deﬁcits from a global pattern of neurological
compromise, which were predictive of later suicide.
Over 90% of all suicides can be attributed to a psychiatric
diagnosis,
13 with depression and bipolar disorder carrying the
highest risk.
14,15 This was consistent within our cohort, all of
whom were diagnosed as clinically depressed or as having a
mood disorder through the BDI, Structured Clinical Interview
for Diagnosis for DSM-IV or psychiatric evaluation. Neuro-
imaging has been a useful tool to demonstrate the link
between depression, serotonergic dysfunction and suicide.
Post-mortem studies of suicide patients found decreased
5-hydroxytryptamine (5-HT1A)/5-HT2A receptor binding in the
ventrolateralprefrontalcortex,spurringinvivoimagingworkin
this area.
16 SPECT imaging studies have conﬁrmed reduced
binding of 5-HT2Aa receptors in the frontal lobes of suicide
attempters
17,18 and decreased serotonin transporter avail-
ability in suicide attempters with 5-HTT polymorphisms
19
indicative of serotonin abnormalities playing a role in suicide
risk. Verbal ﬂuency tasks have been used as a measure of
executive ability in SPECT imaging, indicating prefrontal
cortex function.
20 Audenaert et al.
21 showed decreased
prefrontal perfusion correlated with poor performance on a
verbal ﬂuency task in depressed suicidal patients. Given that
our study demonstrates decreased perfusion bilaterally in the
superior/medial prefrontal cortex in a cohort of completed
suicides with depression as a comorbid factor, it indicates
potential deﬁcits in the serotonergic system as well as in tasks
associated with this brain region, including attention, memory
and executive function.
In addition to elucidating the involvement of the serotonin
system in suicidal behavior (5-HT1A/5-HT2A receptor binding,
5-HTP receptor density, serotonin transporter polymorph-
isms), understanding the personality traits (impulsivity,
aggression, anger, hopelessness) associated with suicidal
ideationandsuicide attempt isprudent.Ourdata demonstrate
extreme deﬁcits in the frontal cortex (the second and third
most signiﬁcant brain region decreased), indicating that our
patient population was at high risk for problems with impaired
judgment. Jollant et al.
22 and others have shown that
dysfunction in the orbitofrontal cortex is associated with
suicide attempts and the tendency to make risky (disadvanta-
geous) behavior choices. Within our cohort, not only were 13
subjects clinically diagnosed with attentional problems,
10 had a history of prior suicide attempt. High impulsivity is
a predictor of self-aggression,
23 and when combined with a
prior history of suicide attempt, it ampliﬁes the risk for suicide
completion.
In examining our data, we wanted to further elucidate the
relationship between the various hypoperfused brain regions
and their respective inﬂuence on the self and the ability to
cope with physical, mental and emotional pain. We found
that the most pronounced region of decreased rCBF was in
Table 4 Top 10 regions of decreased rCBF predictive of suicide in depressed suicidal patients versus depressed non-suicidal patients
Brain area Cluster size t x y z
Temporal inferior lobe/right precentral gyrus 4110 3.42 55  54  4
Left temporal lobe 1422 3.17  58  58  10
Right temporal pole/left hippocampus/right rectus 2206 3.15 46 20  16
Right superior motor area/cingulum 1365 2.95 10  10 60
Right midfrontal lobe/frontal inferior triangularis 406 2.95 42 52 16
Left superior parietal lobe 969 2.93  18 78 50
Pre- and postcentral gyrus/left frontal inferior operculum 774 2.85  56  25 0
Left superior temporal pole 279 2.84  46 14  20
Left and right cerebellum 190 2.81  8  74  50
Frontal medial orbital/right frontal superior 106 2.77 12 64  12
Abbreviation: rCBF, regional cerebral blood ﬂow.
Figure 5 Three-dimensional (3D) surface images showing regional cerebral
blood ﬂow (rCBF) deﬁcits predictive of suicide completion in suicide cohort versus a
depressed non-suicidal clinical population. Cortical surface views showing areas of
decreased rCBF predictive of suicide in completers versus depressed non-suicidal
subjects with matched diagnostic proﬁles at Po0.01, without family-wise error
(FWE). Signiﬁcant decreases are in blue.
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24
and reﬂections upon the self.
25 This was followed by the
prefrontal cortex, which not only was important in drive and
executive function, but also in processing information about
theself,
25–27aswellasincopingwithnegativeemotions
28and
rejection.
29 Other deﬁcits include the rolandic operculum
and postcentral gyrus, areas involved in processing sensory
input, along with the caudate and thalamus, regions which
contribute to emotional processing. Finally, we observed
decreases in the insular cortex, a component of the limbic
systeminvolvedinthemanagementofphysicalandemotional
pain.
30Overactivityoftherightanteriorinsularcortexandright
ventral prefrontal cortex have been found to be involved in
processing frustration.
31 Taken together, global deﬁcits
across these emotion encoding circuits may result in the
underlying inability to properly perceive the self and to cope
with life events, which result in the hopelessness and social
isolation so commonly observed in those who commit suicide.
This situation becomes exacerbated when combined with
other factors, including depression, anxiety, post-traumatic
stress disorder, drug use, head trauma and sexual abuse.
Developing new diagnostic markers is one way to reduce
the prevalence of suicide. In our cohort of completed suicides,
the subgenual cingulate cortex (BA 25) was found to be
hypoperfused in 18 patients as compared with a healthy brain
group. This is a signiﬁcant ﬁnding, which implies that this
region may serve as a potential neuroimaging biomarker for
suicide. BA 25 is a region found to modulate human mood
states and helps to integrate cognitive and emotional
information. It is also an area well populated with serotonin
receptors. If deﬁcits in BA 25 are combined with decreased
rCBF in the prefrontal cortex, an area associated with
executive function and impulsivity, the risk factors for suicide
increase exponentially. We believe this to be the case in our
cohort,as13subjects werediagnosedwith ADHD.Therefore,
the combination of impulsivity, decreased rCBF in BA 25 and
depression elevates patients into a high-risk category for
suicidal behavior.
Our secondary ﬁnding demonstrates more subtle, global
decreases in blood ﬂow and activity patterns in the suicide
groupversusamatchedclinicalpopulationofdepressed,non-
suicidal individuals. Factorial modeling revealed this effect
was weak (at Po0.01 without FWE). This suggests that the
rCBF proﬁle is too diffuse to distinguish speciﬁc patterns that
will help the clinician identify the depressed, suicidal patient
from the depressed non-suicidal patient. However, given the
signiﬁcant rCBF deﬁcits between suicide completers and non-
suicidal depressed patients, it may be that the differentiating
factor is the degree to which the metabolic activity of the brain
is compromised versus speciﬁc regional differences in blood
ﬂow. A more deﬁnitive answer to this question will require
increasing the number of patients studied to identify regional
patterns between these two clinical populations.
The data in this paper not only support our previous work,
9
but extend it to include signiﬁcant deﬁcits in rCBF to the
emotional regulating circuits of the putamen, caudate,
thalamus and insula, and also to highlight BA 25 as a potential
biomarker for suicide. We propose that hypoperfusion of the
prefrontal cortex and BA 25, along with dysregulation of the
emotional circuits representing the self and the ability to cope
with pain, may make a depressed patient more vulnerable to
suicide. More research is needed to replicate our ﬁndings and
to deﬁne the relative importance of any functional brain
deﬁciencies predictive of suicide.
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